Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keerthi Talari

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Osteoarthritis and Cartilage Open|January 15, 2026
Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 studyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
The American Journal of Sports Medicine|June 27, 2023
Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled StudyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
Rheumatology (Oxford, England)|October 25, 2022
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD studyMrinalini Dey, Naveen R, Elena Nikiphorou, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Osteoarthritis and Cartilage Open|January 15, 2026
Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 studyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
The American Journal of Sports Medicine|June 27, 2023
Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled StudyPawan Kumar Gupta, Sunil Maheshwari, Joe Joseph Cherian, et al.
Rheumatology (Oxford, England)|October 25, 2022
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD studyMrinalini Dey, Naveen R, Elena Nikiphorou, et al.
Pageof 2